PubRank

Repeat course of rabbit antithymocyte globulin as salvage following initial therapy with rabbit antithymocyte globulin in acquired aplastic anemia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25862703)

Published in Haematologica on April 10, 2015

Authors

Diego V Clé1, Elias H Atta2, Danielle S P Dias3, Carlos B L Lima3, Mariana Bonduel4, Gabriela Sciuccati4, Larissa A Medeiros5, Michel M de Oliveira5, Marco A Salvino6, Marlene Garanito7, Sara T Ollala Saad8, Rodrigo T Calado9, Phillip Scheinberg10

Author Affiliations

1: Division of Hematology, University of São Paulo at Ribeirão Preto School of Medicine, Ribeirão Preto, Brasil dvcle@hcrp.usp.br.
2: CEMO, National Cancer Institute, Rio de Janeiro, Brasil.
3: Hematopoietic Stem Cell Program, Hemorio, Rio de Janeiro, Brasil.
4: Servicio de Hematología-Oncología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.
5: Bone Marrow Transplantation unit, Federal University of Paraná, Curitiba, Brasil.
6: Bone Marrow Transplantation unit, Federal University of Bahia, Salvador.
7: Child's Institute, University of São Paulo, Brasil.
8: National Institute of Science and Technology of Blood, University of Campinas, Brasil.
9: Division of Hematology, University of São Paulo at Ribeirão Preto School of Medicine, Ribeirão Preto, Brasil.
10: Division of Hematology, University of São Paulo at Ribeirão Preto School of Medicine, Ribeirão Preto, Brasil Clinical Hematology, Antônio Ermírio de Moraes Cancer Center, Hospital São José e Beneficência Portuguesa, São Paulo, Brasil.

Associated clinical trials:

Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia | NCT01297972

Articles cited by this ↗

Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med (2012) 3.93

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA (2003) 3.90

Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med (2011) 3.82

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood (2013) 1.97

Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood (1995) 1.91

Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood (2000) 1.79

Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol (2006) 1.68

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol (1988) 1.66

Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood (1975) 1.46

Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol (2010) 1.30

Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood (2012) 1.20

Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. Br J Haematol (1998) 1.14

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia. Blood (2011) 1.04

Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia. Am J Hematol (2014) 0.83

Rabbit ATG for aplastic anaemia treatment: a backward step? Lancet (2011) 0.79